Ikarian Capital, LLC Synaptogenix, Inc. Transaction History

Ikarian Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$3.88 - $7.41 $124,295 - $237,379	-32,035 Reduced 20.91%	121,191 $614,000
Q1 2022 May 13, 2022	BUY	$6.31 - $10.09 $47,937 - $76,653	7,597 Added 5.22%	153,226 $1.19 Million
Q4 2021 Feb 14, 2022	SELL	$8.38 - $13.72 $838,000 - $1.37 Million	-100,000 Reduced 40.71%	145,629 $1.24 Million
Q3 2021 Nov 15, 2021	SELL	$6.65 - $12.1 $361,567 - $657,889	-54,371 Reduced 18.12%	245,629 $2.44 Million
Q2 2021 Aug 16, 2021	BUY	$5.12 - $11.13 $1.54 Million - $3.34 Million	300,000 New	300,000 $2.96 Million

30K

Ticker SNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 6,840,630
Market Cap $20.2M
Description
Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodeg...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.